drugset / Trial / NCT02991417

Oral Vaccination Against Clostridium Difficile Infection

NCT02991417 ↗

Phase 1 Terminated 3 enrolled Simon M. Cutting
NaSingle-groupOpen-labelPrevention

Summary

This clinical study is conducted to assess the safety and immunogenicity of a Clostridium difficile vaccine (CDVAX) in healthy adult volunteers.

Timeline

Start
2017-01
Primary completion
2017-03-14
Completion
2017-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject CDVAX Vaccine — Oral